BRKR

BrukerC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

Current thesis

The checked post-earnings evidence supports only a cautious bull case: Bruker beat the Zacks-tracked Q1 consensus on both adjusted EPS ($0.31 vs $0.23) and revenue ($823.4 million vs $800.1 million), while management reaffirmed full-year revenue and EPS guidance and pointed to high-single-digit BSI organic bookings with book-to-bill above 1.0x for a third straight quarter.

Posture

Mixed

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.1.

What can break

Bruker reported total outstanding debt of about $1.7 billion as of March 31, 2026, limiting room for a more aggressive bullish stance until revenue conversion improves [#10-Q-2026-05-07].

Momentum

Value

Sentiment

Setup hits (3d)

— · Net —

AI TargetsBase $45.00 · Bull $50.00 · Bear $39.00

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

As of 2026-05-08 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade C · Mixed

Confidence Medium · Net —

Target $59.75

Why

Momentum78 · Δ7d -9.8

Value58 · Δ7d -0.1

Sentiment22 · Δ7d +0.3

So what

Balanced signals. Wait for confirmation before sizing up.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Value · See fundamentals

Momentum

26% active weight

Current posture

7d trendSoftening

Δ7d

-9.8

Δ21d

-20.7

Value

39% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

+0.0

Sentiment

34% active weight

Current posture

7d trendFlat

Δ7d

+0.3

Δ21d

+1.7

Why this grade

Composite grade C. Momentum 78.4 / Value 58.0 / Sentiment 22.4

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$8.86B

Beta

1.18

Shares Out

152.23M

P/E (TTM)

184.1

P/S (TTM)

2.26

P/FCF (TTM)

346.07

Rev YoY

+2.7%

EPS YoY

-80.0%

Gross Margin

+46.3%

Op Margin

+1.1%

Net Debt

$1.74B

Current Ratio

1.55

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology